About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD27.18
- USD27.39
- USD26.07
- USD36.36
- -13.60%
- 6M
- 1.54M
- 1.80M
- 4.4B
- 6.64
- 158.50%
Stock News
yesterday
: Government shutdown: Video reportedly shows Rep. Jamaal Bowman pulling fire alarm as House scrambles to vote on spending bill
MarketWatch
yesterday
Commodities Corner: Why gasoline prices are set to fall even as oil marches toward $100 a barrel
MarketWatch
yesterday
Living With Climate Change: Here’s how El Niño will impact winter, including skiing and snowboarding plans
MarketWatch
yesterday
These are the top 4 Club stocks — and the bottom 4 — during the third quarter
CNBC
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
